You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. ACCELERATE DIAGNOSTICS INC

Accelerate Diagnostics Inc XNAS: AXDX

Accelerate Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Download real time

0.57 0.04 (7.55%)

72.73% Fall from 52W High

29,244 XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

Accelerate Diagnostics Inc Key Metrics

Default

Market Capitalization

Low in industry
14.3

PE TTM

Negative PE TTM
-0.3

Price to Book

Negative Price to Book
-0.3

Institutional holding current Qtr %

Below industry Median
19.3

Revenue Growth Qtr YoY %

Negative Revenue Growth Qtr YoY %
-7

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
-3

Net Profit Qtr Growth YoY %

Below industry Median
26.2

Net Profit TTM Growth %

Below industry Median
18.8

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-281.7

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-301.9

Piotroski Score

Below industry Median
2

Rel Perf vs Sector quarter%

-40.3

RoA Annual %

Negative RoA Annual %
-167
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
11.5 / 100
Momentum Score
Technically Bearish
24.0 / 100
Analyst Price Target
No estimates available

11

S

14

W

2

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Accelerate Diagnostics Inc Live Price Chart

Switch to TradingView
Fetching data ...

Accelerate Diagnostics Inc Stock Analysis

Accelerate Diagnostics Inc stock analysis with key metrics, changes, and trends.

Accelerate Diagnostics Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$11.7 M2.99%negative

Annual Revenue fell 2.99%, in the last year to $11.7 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$50.04 M18.78%positive

Annual Net Profit rose 18.78% in the last year to $50.04 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio-0.29-negative

Price to Earning Ratio is -0.29, which is negative.

Stock Price$0.57-33.72%negative

Stock Price fell 33.72% and underperformed its sector by 41.43% in the past year.

Quarterly Revenue$2.82 M6.97%negative

Quarterly Revenue fell 6.97% YoY to $2.82 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$9.59 M26.23%positive

Quarterly Net profit rose 26.23% YoY to $9.59 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Mutual Fund Holding4.92 %0.02%positive

Mutual Fund Holding increased by 0.02% in the last quarter to 4.92.

Promoter Share Holding1.15 %0.08%positive

Promoter Share Holding increased by 0.08% in the most recent quarter to 1.15%.

Interest Coverage Ratio-2.82-negative

Interest Coverage Ratio is -2.82, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding19.26 %-0.6%negative

Institutional Holding decreased by 0.6% in the last quarter to 19.26.

VIEW LESS


Loading data..

Accelerate Diagnostics Inc - Company Profile

What does Accelerate Diagnostics Inc do?

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

Accelerate Diagnostics Inc Management structure

All Gross Remunerations are in USD
Mr. John Phillips
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. David Patience
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Accelerate Diagnostics Inc Board of directors

All Gross Remunerations are in USD
Mr. Paul Shalhoub
Independent Director
-
2025
Gross Remuneration
Year
Mr. Gilbert Nathan
Independent Director
-
2025
Gross Remuneration
Year

Accelerate Diagnostics Inc FAQ

How is Accelerate Diagnostics Inc today?
Accelerate Diagnostics Inc today is trading in the green, and is up by 7.55% at 0.57.
Accelerate Diagnostics Inc is currently trading up 7.55% on an intraday basis. In the past week the stock rose 3.64%. stock has been down -49.11% in the past quarter and fell -33.72% in the past year. You can view this in the overview section.